These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19389858)

  • 21. Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.
    Chancellor MB; Staskin DR; Kay GG; Sandage BW; Oefelein MG; Tsao JW
    Drugs Aging; 2012 Apr; 29(4):259-73. PubMed ID: 22390261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.
    Washington CB; Wiltshire HR; Man M; Moy T; Harris SR; Worth E; Weigl P; Liang Z; Hall D; Marriott L; Blaschke TF
    Drug Metab Dispos; 2000 Sep; 28(9):1058-62. PubMed ID: 10950849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier.
    Milane A; Fernandez C; Vautier S; Bensimon G; Meininger V; Farinotti R
    J Neurochem; 2007 Oct; 103(1):164-73. PubMed ID: 17635670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
    Staskin D; Sand P; Zinner N; Dmochowski R;
    J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood-brain barrier P-glycoprotein effect.
    Padowski JM; Pollack GM
    Brain Res; 2011 Dec; 1426():1-17. PubMed ID: 22036081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin.
    Zong J; Pollack GM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):556-62. PubMed ID: 12721332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
    Murata M; Tamai I; Kato H; Nagata O; Tsuji A
    J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein.
    Bonhomme-Faivre L; Benyamina A; Reynaud M; Farinotti R; Abbara C
    Addict Biol; 2008 Sep; 13(3-4):295-300. PubMed ID: 18331373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.
    Smit JW; Huisman MT; van Tellingen O; Wiltshire HR; Schinkel AH
    J Clin Invest; 1999 Nov; 104(10):1441-7. PubMed ID: 10562306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-Glycoprotein efflux reduces the brain concentration of the substance P (NK1 receptor) antagonists SR140333 and GR205171: a comparative study using mdr1a-/- and mdr1a+/+ mice.
    Rupniak NM; Fisher A; Boyce S; Clarke D; Pike A; O'Connor D; Watt A
    Behav Pharmacol; 2003 Sep; 14(5-6):457-63. PubMed ID: 14501258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice.
    Salama NN; Kelly EJ; Bui T; Ho RJ
    J Pharm Sci; 2005 Jun; 94(6):1216-25. PubMed ID: 15858856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain penetration of the OAB drug trospium chloride is not increased in aged mice.
    Kranz J; Petzinger E; Geyer J
    World J Urol; 2013 Feb; 31(1):219-24. PubMed ID: 22120415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a P-glycoprotein knockout model in rodents to define species differences in its functional effect at the blood-brain barrier.
    Cutler L; Howes C; Deeks NJ; Buck TL; Jeffrey P
    J Pharm Sci; 2006 Sep; 95(9):1944-53. PubMed ID: 16850390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
    Mayer U; Wagenaar E; Dorobek B; Beijnen JH; Borst P; Schinkel AH
    J Clin Invest; 1997 Nov; 100(10):2430-6. PubMed ID: 9366556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of trospium chloride therapy on intraocular pressure and tear secretion in overactive bladder patients.
    Turkoglu AR; Parmak Yener N; Coban S; Guzelsoy M; Emul A; Demirbas M; Demirci H
    Cutan Ocul Toxicol; 2017 Dec; 36(4):331-335. PubMed ID: 28468509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice.
    Desrayaud S; De Lange EC; Lemaire M; Bruelisauer A; De Boer AG; Breimer DD
    J Pharmacol Exp Ther; 1998 May; 285(2):438-43. PubMed ID: 9580581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder.
    Haupt M; Thommes M; Heidenreich A; Breitkreutz J
    J Control Release; 2013 Sep; 170(2):161-6. PubMed ID: 23732944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice.
    Leusch A; Volz A; Müller G; Wagner A; Sauer A; Greischel A; Roth W
    Eur J Pharm Sci; 2002 Aug; 16(3):119-28. PubMed ID: 12128165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of trospium chloride.
    Doroshyenko O; Jetter A; Odenthal KP; Fuhr U
    Clin Pharmacokinet; 2005; 44(7):701-20. PubMed ID: 15966754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evaluation of [123I]-4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(4-iodobenzyl)piperidine, an iodinated SPECT tracer for imaging the P-gp transporter.
    De Bruyne S; Wyffels L; Boos TL; Staelens S; Deleye S; Rice KC; De Vos F
    Nucl Med Biol; 2010 May; 37(4):469-77. PubMed ID: 20447559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.